China News Service, Beijing, January 4th, title: The epidemic has brought about the advancement of the concept of "preventing disease". Chinese private vaccine companies also gain new opportunities
Author Li Hanxue
The challenging 2020 is over suddenly.
For the Chinese private vaccine company Chongqing Zhifei Biological Products Company, although production was temporarily suspended during the epidemic, a new development opportunity has already arrived.
"The outbreak of the epidemic is something we don't want to see, but objectively speaking, the epidemic has made people pay more attention to health and vaccines." Zhifei Bio-Chairman Jiang Rensheng said in an exclusive interview with China News Agency recently that the epidemic has brought the people a time. Realistic, comprehensive and profound disease prevention education.
To a certain extent, we have experienced an unprecedented disease prevention and control propaganda. Whether in urban or rural areas, people’s willingness to understand and learn about infectious disease prevention has greatly increased, and health awareness and awareness of infectious disease prevention and control have generally increased. The willingness to vaccinate has also increased.
"We have paid a great price for this epidemic. But in terms of changing people's concept of "treating the disease" to "preventing the disease", it has indeed promoted the advancement of disease prevention." Jiang Rensheng said that the public's awareness of prevention has improved. , The demand for the vaccine market will naturally increase, which is definitely good for Zhifei's future development.
But as a member of the epidemic prevention front and a company that serves health, we see more responsibility.
He believes that only by adhering to the tenet of "social benefit first, business benefit second", so that more regions and more groups can receive medical protection, and more families will no longer cause poverty and return to poverty due to illness, can we be worthy of the trust of the people.
Passing through 2020 is not easy, and the positive trends in the economic environment have given Jiang Rensheng a sign of optimism.
Last year, in the context of the global pandemic of COVID-19 and poor economic cycles, China proposed to "accelerate the construction of a new development pattern with domestic and international cycles as the mainstay".
Jiang Rensheng believes that private enterprises "effectively benefit from the guarantee of the policy environment."
He said that in the process of forming this new development pattern, China firmly implemented the strategy of expanding domestic demand, tapped the potential of the domestic market, promoted consumption, and expanded investment space, so that private enterprises have more room for domestic demand.
The state promotes the improvement of key core technology innovation capabilities, and also promotes product upgrades and new drug development in the pharmaceutical industry.
The epidemic has affected overseas supply, forcing domestic development of import substitution, giving more opportunities for domestic products and benefiting the development of private enterprises.
In November last year, the Chinese government and the ten ASEAN countries, Japan, South Korea, Australia, and New Zealand jointly signed the "Regional Comprehensive Economic Partnership Agreement" ("RCEP").
Jiang Rensheng believes that RCEP will help promote China's high-level reform and opening up, improve the quality of domestic goods and services, and promote the expansion and quality of domestic consumption.
For the development of Zhifei, "the cooperation in product, technology, investment, and supply chain will have broader prospects."
He mentioned that RCEP provides the integration possibility for the development of regional medicine and health products.
In this environment, it is possible for domestic products to gradually spread and extend to the region, and have the opportunity to participate in regional and even global cooperation and competition, and to serve a broader group.
Jiang Rensheng lamented that the epidemic is a test of anti-risk ability for private enterprises, especially vaccine companies.
The phrase "opportunities and challenges coexist" can truly describe Zhifei's 2020.
Jiang Rensheng said that in the future, he will cherish the development platform provided by the state, actively deploy, concentrate on research and development, provide support and protection for national health, and contribute the strength of private enterprises to a healthy China.
(Finish)